Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.16 Bil Enterprise Value: 9.58 Bil PE Ratio: 106.36 PB Ratio: 2.73 GF Score: 85/100

Thermo Fisher Scientific Inc to Acquire Qiagen NV Call Transcript

Mar 03, 2020 / 01:30PM GMT
Release Date Price: €38.24 (+16.98%)
Operator

Good morning, ladies and gentlemen, and welcome to today's conference call and webcast to discuss Thermo Fisher Scientific's acquisition of QIAGEN.

I would like to introduce our moderator for the call. Mr. Kenneth Apicerno, Vice President, Investor Relations. Mr. Apicerno, you may begin the call.

Kenneth Apicerno

Thank you, and good morning, everyone. Welcome to our conference call to discuss Thermo Fisher's acquisition of QIAGEN, which, as you all know, we announced earlier today.

On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer; and Stephen Williamson, our Chief Financial Officer. You'll find a brief presentation deck in the Investors section of our website, thermofisher.com, under the section titled Webcasts and Presentations. We'll walk through that deck on the call this morning, and after prepared comments, we'll open it up for Q&A.

Please note, this call is being webcast live and will be archived on the Investors section of our website, thermofisher.com, under the heading Webcasts and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot